Tacrolimus Oral Capsule 0.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Tacrolimus: Oral capsule (0.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_15713.JPG
Tacrolimus 0.5mg Cap
Dr. Reddy's Laboratories, Inc.
Pill Identification: 0.5MG RDY 525 
Drug Image file default-drug-image.png
Tacrolimus 0.5mg Cap
Drug Image file DrugItem_14269.JPG
Tacrolimus 0.5mg Cap
Sandoz Inc
Pill Identification: LOGO 643 

What is this Medicine?

TACROLIMUS (ta KROE li mus) is used to decrease the immune system's response to a transplanted organ.

CVS Pharmacy Patient Statistics for Tacrolimus: Oral capsule(0.5mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Tacrolimus 0.5mg Capsule

NDC: 551110525
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Heart Transplant Rejection Prophylaxis, Liver Transplant Rejection Prophylaxis, Kidney Transplant Rejection Prophylaxis

Sometimes used for but not FDA approved for the following conditions:
Kidney Transplant Rejection, Small Bowel Transplant Rejection Prophylaxis, Uveitis, Pancreas Transplant Rejection Prophylaxis, Graft-versus-host Disease (GVHD) Prophylaxis, Graft-versus-host Disease (GVHD), Nephrotic Syndrome, Lung Transplant Rejection, Lupus Nephritis, Lung Transplant Rejection Prophylaxis, Liver Transplant Rejection, Heart Transplant Rejection, Psoriasis, Ulcerative Colitis

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Tacrolimus 0.5mg Capsule
Drug Image file DrugItem_15713.JPG
Dr. Reddy's Laboratories, Inc.
Pill Identification: 0.5MG RDY 525 
Shape: capsule
Color: yellow

Reported Side Effects for Tacrolimus 0.5mg Capsule

Vaginal Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
<59.0%*
Severity: MILD
Onset: EARLY
Cholestasis Incidence:
<15.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
<15.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Pancreas Incidence:
<15.0%*
Severity: SEVERE
Onset: DELAYED
High Red Blood Cells Incidence:
<15.0%*
Severity: MODERATE
Onset: DELAYED
Secondary Malignancy Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Chills Incidence:
<15.0%*
Severity: MILD
Onset: RAPID
Bruise Incidence:
<15.0%*
Severity: MILD
Onset: DELAYED
Heartburn Incidence:
<15.0%*
Severity: MILD
Onset: DELAYED
Increased Urination Incidence:
<15.0%*
Severity: MILD
Onset: EARLY
Nighttime Urination Incidence:
<15.0%*
Severity: MILD
Onset: EARLY
Stomach Ulcer Incidence:
<15.0%*
Severity: SEVERE
Onset: DELAYED
Pus In Urine Incidence:
<15.0%*
Severity: MODERATE
Onset: DELAYED
Kidney Damage Incidence:
<15.0%*
Severity: SEVERE
Onset: DELAYED
Post-transplant Lymphoproliferative Disorder (PTLD) Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Extra Abdominal Fluid Incidence:
<15.0%*
Severity: MODERATE
Onset: DELAYED
Bladder Spasm Incidence:
<15.0%*
Severity: MODERATE
Onset: EARLY
Bladder Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Dehydration Incidence:
<15.0%*
Severity: MODERATE
Onset: DELAYED
Painful Urination Incidence:
<15.0%*
Severity: MODERATE
Onset: EARLY
Retaining Urine Incidence:
<15.0%*
Severity: MODERATE
Onset: EARLY
Uncontrolled Urination Incidence:
<15.0%*
Severity: MODERATE
Onset: EARLY
Decreased Appetite Incidence:
0.2-34.0%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
0.2-1.0%*
Severity: MILD
Onset: EARLY
High Bilirubin Level Incidence:
0.2-15.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Stomach Incidence:
0.2-15.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Colon Incidence:
0.2-15.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
0.2-40.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Sores Incidence:
0.2-1.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
0.2-15.0%*
Severity: MODERATE
Onset: DELAYED
Metallic Taste Incidence:
0.2-1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.0-46.0%*
Severity: MILD
Onset: EARLY
Enlarged Lymph Nodes Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Menstrual Cramps Incidence:
1.0-4.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
1.0-29.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
1.0-48.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.0-28.0%*
Severity: MILD
Onset: EARLY
Yellow Skin Incidence:
3.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
3.0-15.0%*
Severity: MILD
Onset: DELAYED
Bowel Obstruction Incidence:
3.0-15.0%*
Severity: SEVERE
Onset: DELAYED
Cholangitis Incidence:
3.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
3.0-15.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
3.0-36.0%*
Severity: MODERATE
Onset: DELAYED
Throat Inflammation Incidence:
3.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Difficulty Swallowing Incidence:
3.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Causing To Be Hungry Incidence:
3.0-15.0%*
Severity: MILD
Onset: DELAYED
Intestinal Bleeding Incidence:
3.0-15.0%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
3.0-72.0%*
Severity: MILD
Onset: EARLY
Hole In Intestines Incidence:
3.0-15.0%*
Severity: SEVERE
Onset: DELAYED
Liver Infection Incidence:
3.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Throat Ulcers Incidence:
3.0-15.0%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
5.0-50.0%*
Severity: MODERATE
Onset: DELAYED
High White Blood Cells Incidence:
8.0-32.0%*
Severity: MILD
Onset: DELAYED
Low White Blood Cell Counts Incidence:
13.0-48.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
14.0-24.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Tacrolimus 0.5mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Severe Lifestyle Interaction
Grapefruit juice and Tacrolimus 0.5mg Capsule(Tacrolimus)
Grapefruit juice and Tacrolimus(Tacrolimus)
Avoid grapefruit juice while taking Tacrolimus. Grapefruit and Grapefruit juice increase Tacrolimus blood levels significantly leading to side effects like abdominal pain, confusion, decreased urination, dizziness, headache, mood changes, nausea-vomiting, tremor, yellowing of skin or eyes, weakness, or other problems. An interaction with topical Tacrolimus is unlikely.
Severe Lifestyle Interaction
Food and Tacrolimus 0.5mg Capsule(Tacrolimus)
Food and Tacrolimus (Oral)(Tacrolimus)
Tacrolimus may be taken with or without food, but it is critical that you always take tacrolimus consistently with or without food to maintain consistent blood levels of this drug. Avoid grapefruit juice while taking Tacrolimus. Grapefruit and Grapefruit juice increase Tacrolimus blood levels significantly leading to side effects like abdominal pain, confusion, decreased urination, dizziness, headache, mood changes, nausea-vomiting, tremor, yellowing of skin or eyes, weakness, or other problems. An interaction with topical Tacrolimus is unlikely.
Major Lifestyle Interaction
Alcohol and Tacrolimus 0.5mg Capsule(Tacrolimus)
Alcohol and Tacrolimus(Tacrolimus)
Do not drink alcoholic beverages while taking Tacrolimus extended-release capsules (Astagraf XL). Alcohol may increase blood levels of Astagraf XL and increase the risk of serious side effects. In roughly 3 to 7 out of every 100 persons using topical tacrolimus (Protopic), drinking alcohol may cause the skin or face to become flushed or red and feel hot. Let your prescriber know if you notice such reactions, particularly if they are bothersome. In some cases, your prescriber can recommend a treatment that might lessen the reaction when you drink alcohol socially. If the reaction is particularly uncomfortable, it may be best to limit your alcohol intake.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Tacrolimus

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5